PlainRecalls
FDA Drug Moderate Class II Terminated

Xylocaine-MPF with Epinephrine 1:200,000, (Lidocaine HCl and Epinephrine Injection, USP), 1%, 300 mg/30 mL, (10 mg/mL), 30 mL Single Dose Vial, 25 Vials per Tray, Rx only, Fresenius Kabi USA, LLC, Lake Zurich, IL 60047. Vial NDC 63323-487-07, Tray NDC 63323-487-37

Reported: July 14, 2021 Initiated: June 25, 2021 #D-0651-2021

Product Description

Xylocaine-MPF with Epinephrine 1:200,000, (Lidocaine HCl and Epinephrine Injection, USP), 1%, 300 mg/30 mL, (10 mg/mL), 30 mL Single Dose Vial, 25 Vials per Tray, Rx only, Fresenius Kabi USA, LLC, Lake Zurich, IL 60047. Vial NDC 63323-487-07, Tray NDC 63323-487-37

Reason for Recall

Low out of specification results for epinephrine assay.

Details

Recalling Firm
Fresenius Kabi USA LLC
Units Affected
234,800 vials
Distribution
Distributed Nationwide in the USA
Location
Melrose Park, IL

Frequently Asked Questions

What product was recalled?
Xylocaine-MPF with Epinephrine 1:200,000, (Lidocaine HCl and Epinephrine Injection, USP), 1%, 300 mg/30 mL, (10 mg/mL), 30 mL Single Dose Vial, 25 Vials per Tray, Rx only, Fresenius Kabi USA, LLC, Lake Zurich, IL 60047. Vial NDC 63323-487-07, Tray NDC 63323-487-37. Recalled by Fresenius Kabi USA LLC. Units affected: 234,800 vials.
Why was this product recalled?
Low out of specification results for epinephrine assay.
Which agency issued this recall?
This recall was issued by the FDA Drug on July 14, 2021. Severity: Moderate. Recall number: D-0651-2021.